NuMedii
The AI engine Fit Assessment
BetaNuMedii effectively leverages machine learning and AI to discover new patterns, expand therapeutic options, and identify potential drug repurposing opportunities.
Blurb
NuMedii is a biotechnology company that discovers and de-risks effective drugs by translating life sciences big data into therapies.
HQ Location
Menlo Park (United States)
Founded
2008
Employees
11 - 50
Total funding raised
$5.50M
Last Funding Event
Series A, $2.00M, August 17, 2015
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
NuMedii is a biotechnology company that discovers and de-risks effective new drugs by translating life sciences big data into therapies. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii. It utilizes hundreds of millions of raw human, biological, pharmacological, and clinical data points. The company was founded in 2008 and headquartered in San Mateo, California.